Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions
The purpose of the study was to compare three types of general anesthesia for functional endoscopic sinus surgery (ESS) with controlled hypotension measuring the quality of visibility of the surgical field and the blood loss during the operation. Seventy-one patients underwent endoscopic ethmoidecto...
Gespeichert in:
| Veröffentlicht in: | O.R.L. Journal for oto-rhino-laryngology and its related specialties 2005-01, Vol.67 (2), p.83-86 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 86 |
|---|---|
| container_issue | 2 |
| container_start_page | 83 |
| container_title | O.R.L. Journal for oto-rhino-laryngology and its related specialties |
| container_volume | 67 |
| creator | Manola, M. De Luca, E. Moscillo, L. Mastella, A. |
| description | The purpose of the study was to compare three types of general anesthesia for functional endoscopic sinus surgery (ESS) with controlled hypotension measuring the quality of visibility of the surgical field and the blood loss during the operation. Seventy-one patients underwent endoscopic ethmoidectomy bilaterally for nasal polyposis and/or chronic sinusitis. The patients were divided into three groups according to the type of anesthesia they had: group A (sufentanil/sevoflurane), group B (remifentanil/propofol), and group C (fentanyl/isoflurane). The mean estimated blood loss for group A was 117.83 ml, for group B it was 100.5 ml and for group C it was 198.89 ml. The average quality of visibility of the surgical field was 1.57 for group A, 1.3 for group B and 2.79 for group C. The quantity of blood loss (p < 0.01) and the visibility of the surgical field (p < 0.001) demonstrated a difference among the three groups. Remifentanil and sufentanil during functional ESS enable controlled hypotension and a general improvement in surgical conditions. |
| doi_str_mv | 10.1159/000084576 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_karge</sourceid><recordid>TN_cdi_proquest_journals_225061416</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>863327541</sourcerecordid><originalsourceid>FETCH-LOGICAL-c426t-5cb200734e8157a061b46e68745fa395c68b4a810a0976c280f7aff2926cd9103</originalsourceid><addsrcrecordid>eNpd0M9LwzAUB_AgipvTg2dBiqDgoZqk-dWjjE0HA8G5c8nSdGS2yUxaYf-9mRsbmEtI-Ly8ly8A1wg-IUTzZxiXIJSzE9BHBGcpxJyegj7MIEoRZXkPXISwiopiwc9BD1EuaCztg-U8GLtMPnRjKm1baU2dSFsms-5wNDYZd1a1xllZJyNbuqDc2qhkZmwXovRL7TdJ65JJs_buR_9dGRXx0NnSbAvDJTirZB301X4fgPl49Dl8S6fvr5PhyzRVBLM2pWqBIeQZ0SLOKCFDC8I0E5zQSmY5VUwsiBQISphzprCAFZdVhXPMVJkjmA3Aw-7dOMl3p0NbNCYoXdfSateFgnHBOBEowrt_cOU6H38YCoxpbEwQi-hxh5R3IXhdFWtvGuk3BYLFNvriEH20t_sHu0Wjy6PcZx3B_R7IEMOpvLTKhKOLo3FKt5Pd7NyX3CZ7ALs2vz3hkvg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225061416</pqid></control><display><type>article</type><title>Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions</title><source>MEDLINE</source><source>Karger Journals</source><source>Alma/SFX Local Collection</source><source>Karger:Jisc Collections:ORL, Ophthalmology, Dental Medicine, Obstetrics, Gynecology and Psychology, Psychiatry Archive Collection (2012-2112)</source><creator>Manola, M. ; De Luca, E. ; Moscillo, L. ; Mastella, A.</creator><creatorcontrib>Manola, M. ; De Luca, E. ; Moscillo, L. ; Mastella, A.</creatorcontrib><description>The purpose of the study was to compare three types of general anesthesia for functional endoscopic sinus surgery (ESS) with controlled hypotension measuring the quality of visibility of the surgical field and the blood loss during the operation. Seventy-one patients underwent endoscopic ethmoidectomy bilaterally for nasal polyposis and/or chronic sinusitis. The patients were divided into three groups according to the type of anesthesia they had: group A (sufentanil/sevoflurane), group B (remifentanil/propofol), and group C (fentanyl/isoflurane). The mean estimated blood loss for group A was 117.83 ml, for group B it was 100.5 ml and for group C it was 198.89 ml. The average quality of visibility of the surgical field was 1.57 for group A, 1.3 for group B and 2.79 for group C. The quantity of blood loss (p < 0.01) and the visibility of the surgical field (p < 0.001) demonstrated a difference among the three groups. Remifentanil and sufentanil during functional ESS enable controlled hypotension and a general improvement in surgical conditions.</description><identifier>ISSN: 0301-1569</identifier><identifier>EISSN: 1423-0275</identifier><identifier>DOI: 10.1159/000084576</identifier><identifier>PMID: 15785115</identifier><identifier>CODEN: ORLJAH</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Adjuvants, Anesthesia - administration & dosage ; Adult ; Anesthetics, Intravenous - administration & dosage ; Biological and medical sciences ; Chronic Disease ; Endoscopy - methods ; Female ; Humans ; Male ; Medical sciences ; Middle Aged ; Monitoring, Intraoperative ; Nasal Polyps - surgery ; Original Paper ; Otorhinolaryngologic Surgical Procedures - methods ; Otorhinolaryngology. Stomatology ; Piperidines - administration & dosage ; Retrospective Studies ; Sinusitis - surgery ; Sufentanil - administration & dosage ; Tampons, Surgical</subject><ispartof>O.R.L. Journal for oto-rhino-laryngology and its related specialties, 2005-01, Vol.67 (2), p.83-86</ispartof><rights>2005 S. Karger AG, Basel</rights><rights>2005 INIST-CNRS</rights><rights>Copyright 2005 S. Karger AG, Basel.</rights><rights>Copyright (c) 2005 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c426t-5cb200734e8157a061b46e68745fa395c68b4a810a0976c280f7aff2926cd9103</citedby><cites>FETCH-LOGICAL-c426t-5cb200734e8157a061b46e68745fa395c68b4a810a0976c280f7aff2926cd9103</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,2429,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16787551$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15785115$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Manola, M.</creatorcontrib><creatorcontrib>De Luca, E.</creatorcontrib><creatorcontrib>Moscillo, L.</creatorcontrib><creatorcontrib>Mastella, A.</creatorcontrib><title>Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions</title><title>O.R.L. Journal for oto-rhino-laryngology and its related specialties</title><addtitle>ORL</addtitle><description>The purpose of the study was to compare three types of general anesthesia for functional endoscopic sinus surgery (ESS) with controlled hypotension measuring the quality of visibility of the surgical field and the blood loss during the operation. Seventy-one patients underwent endoscopic ethmoidectomy bilaterally for nasal polyposis and/or chronic sinusitis. The patients were divided into three groups according to the type of anesthesia they had: group A (sufentanil/sevoflurane), group B (remifentanil/propofol), and group C (fentanyl/isoflurane). The mean estimated blood loss for group A was 117.83 ml, for group B it was 100.5 ml and for group C it was 198.89 ml. The average quality of visibility of the surgical field was 1.57 for group A, 1.3 for group B and 2.79 for group C. The quantity of blood loss (p < 0.01) and the visibility of the surgical field (p < 0.001) demonstrated a difference among the three groups. Remifentanil and sufentanil during functional ESS enable controlled hypotension and a general improvement in surgical conditions.</description><subject>Adjuvants, Anesthesia - administration & dosage</subject><subject>Adult</subject><subject>Anesthetics, Intravenous - administration & dosage</subject><subject>Biological and medical sciences</subject><subject>Chronic Disease</subject><subject>Endoscopy - methods</subject><subject>Female</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Monitoring, Intraoperative</subject><subject>Nasal Polyps - surgery</subject><subject>Original Paper</subject><subject>Otorhinolaryngologic Surgical Procedures - methods</subject><subject>Otorhinolaryngology. Stomatology</subject><subject>Piperidines - administration & dosage</subject><subject>Retrospective Studies</subject><subject>Sinusitis - surgery</subject><subject>Sufentanil - administration & dosage</subject><subject>Tampons, Surgical</subject><issn>0301-1569</issn><issn>1423-0275</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpd0M9LwzAUB_AgipvTg2dBiqDgoZqk-dWjjE0HA8G5c8nSdGS2yUxaYf-9mRsbmEtI-Ly8ly8A1wg-IUTzZxiXIJSzE9BHBGcpxJyegj7MIEoRZXkPXISwiopiwc9BD1EuaCztg-U8GLtMPnRjKm1baU2dSFsms-5wNDYZd1a1xllZJyNbuqDc2qhkZmwXovRL7TdJ65JJs_buR_9dGRXx0NnSbAvDJTirZB301X4fgPl49Dl8S6fvr5PhyzRVBLM2pWqBIeQZ0SLOKCFDC8I0E5zQSmY5VUwsiBQISphzprCAFZdVhXPMVJkjmA3Aw-7dOMl3p0NbNCYoXdfSateFgnHBOBEowrt_cOU6H38YCoxpbEwQi-hxh5R3IXhdFWtvGuk3BYLFNvriEH20t_sHu0Wjy6PcZx3B_R7IEMOpvLTKhKOLo3FKt5Pd7NyX3CZ7ALs2vz3hkvg</recordid><startdate>20050101</startdate><enddate>20050101</enddate><creator>Manola, M.</creator><creator>De Luca, E.</creator><creator>Moscillo, L.</creator><creator>Mastella, A.</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20050101</creationdate><title>Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions</title><author>Manola, M. ; De Luca, E. ; Moscillo, L. ; Mastella, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c426t-5cb200734e8157a061b46e68745fa395c68b4a810a0976c280f7aff2926cd9103</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adjuvants, Anesthesia - administration & dosage</topic><topic>Adult</topic><topic>Anesthetics, Intravenous - administration & dosage</topic><topic>Biological and medical sciences</topic><topic>Chronic Disease</topic><topic>Endoscopy - methods</topic><topic>Female</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Monitoring, Intraoperative</topic><topic>Nasal Polyps - surgery</topic><topic>Original Paper</topic><topic>Otorhinolaryngologic Surgical Procedures - methods</topic><topic>Otorhinolaryngology. Stomatology</topic><topic>Piperidines - administration & dosage</topic><topic>Retrospective Studies</topic><topic>Sinusitis - surgery</topic><topic>Sufentanil - administration & dosage</topic><topic>Tampons, Surgical</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Manola, M.</creatorcontrib><creatorcontrib>De Luca, E.</creatorcontrib><creatorcontrib>Moscillo, L.</creatorcontrib><creatorcontrib>Mastella, A.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>O.R.L. Journal for oto-rhino-laryngology and its related specialties</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Manola, M.</au><au>De Luca, E.</au><au>Moscillo, L.</au><au>Mastella, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions</atitle><jtitle>O.R.L. Journal for oto-rhino-laryngology and its related specialties</jtitle><addtitle>ORL</addtitle><date>2005-01-01</date><risdate>2005</risdate><volume>67</volume><issue>2</issue><spage>83</spage><epage>86</epage><pages>83-86</pages><issn>0301-1569</issn><eissn>1423-0275</eissn><coden>ORLJAH</coden><abstract>The purpose of the study was to compare three types of general anesthesia for functional endoscopic sinus surgery (ESS) with controlled hypotension measuring the quality of visibility of the surgical field and the blood loss during the operation. Seventy-one patients underwent endoscopic ethmoidectomy bilaterally for nasal polyposis and/or chronic sinusitis. The patients were divided into three groups according to the type of anesthesia they had: group A (sufentanil/sevoflurane), group B (remifentanil/propofol), and group C (fentanyl/isoflurane). The mean estimated blood loss for group A was 117.83 ml, for group B it was 100.5 ml and for group C it was 198.89 ml. The average quality of visibility of the surgical field was 1.57 for group A, 1.3 for group B and 2.79 for group C. The quantity of blood loss (p < 0.01) and the visibility of the surgical field (p < 0.001) demonstrated a difference among the three groups. Remifentanil and sufentanil during functional ESS enable controlled hypotension and a general improvement in surgical conditions.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>15785115</pmid><doi>10.1159/000084576</doi><tpages>4</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0301-1569 |
| ispartof | O.R.L. Journal for oto-rhino-laryngology and its related specialties, 2005-01, Vol.67 (2), p.83-86 |
| issn | 0301-1569 1423-0275 |
| language | eng |
| recordid | cdi_proquest_journals_225061416 |
| source | MEDLINE; Karger Journals; Alma/SFX Local Collection; Karger:Jisc Collections:ORL, Ophthalmology, Dental Medicine, Obstetrics, Gynecology and Psychology, Psychiatry Archive Collection (2012-2112) |
| subjects | Adjuvants, Anesthesia - administration & dosage Adult Anesthetics, Intravenous - administration & dosage Biological and medical sciences Chronic Disease Endoscopy - methods Female Humans Male Medical sciences Middle Aged Monitoring, Intraoperative Nasal Polyps - surgery Original Paper Otorhinolaryngologic Surgical Procedures - methods Otorhinolaryngology. Stomatology Piperidines - administration & dosage Retrospective Studies Sinusitis - surgery Sufentanil - administration & dosage Tampons, Surgical |
| title | Using Remifentanil and Sufentanil in Functional Endoscopic Sinus Surgery to Improve Surgical Conditions |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T06%3A33%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_karge&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Using%20Remifentanil%20and%20Sufentanil%20in%20Functional%20Endoscopic%20Sinus%20Surgery%20to%20Improve%20Surgical%20Conditions&rft.jtitle=O.R.L.%20Journal%20for%20oto-rhino-laryngology%20and%20its%20related%20specialties&rft.au=Manola,%20M.&rft.date=2005-01-01&rft.volume=67&rft.issue=2&rft.spage=83&rft.epage=86&rft.pages=83-86&rft.issn=0301-1569&rft.eissn=1423-0275&rft.coden=ORLJAH&rft_id=info:doi/10.1159/000084576&rft_dat=%3Cproquest_karge%3E863327541%3C/proquest_karge%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=225061416&rft_id=info:pmid/15785115&rfr_iscdi=true |